SUNPHARMA.NS : Summary for SUN PHARMACEUTICAL INR1(DEMAT) - Yahoo Finance

U.S. Markets closed

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)


NSE - NSE Real Time Price. Currency in INR
Add to watchlist
639.60-16.35 (-2.49%)
At close: 3:30PM IST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close655.95
Open659.45
Bid0.00 x
Ask0.00 x
Day's Range636.60 - 659.45
52 Week Range571.90 - 854.95
Volume6,091,210
Avg. Volume3,013,974
Market Cap1.54T
BetaN/A
PE Ratio (TTM)20.97
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Bloomberg3 days ago

    U.S. FDA Finds Incomplete Lab Records at Sun Pharma Plant

    The U.S. Food and Drug Administration noted incomplete laboratory records among potential manufacturing violations it observed during an inspection of Sun Pharmaceutical Industries Ltd.’s Dadra unit this ...

  • Reuterslast month

    Indian drugmakers face squeeze in U.S. healthcare market

    India's small and medium-sized generic drugmakers say the threat of tougher rules and higher barriers for outsiders in the U.S. healthcare market will force many to find a niche or focus their expansion efforts on other countries. Cut-price generics sold by India's small- and medium-sized drugmakers have been critical in bringing down prices there. A more protectionist stance by President Donald Trump, with the prospect of import tariffs and the U.S. boosting local drug manufacturing, mean the operating environment for smaller generic players will get worse, executives at Indian companies said.

  • Indian Pharma Exits the Trauma Room
    Bloomberglast month

    Indian Pharma Exits the Trauma Room

    Now they just have to survive Dr. Trump's trade prescriptions.